{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:08:36Z","timestamp":1778749716094,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["CPP-329455"],"award-info":[{"award-number":["CPP-329455"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Family Planning Innovation","award":["CRC-2023-00135"],"award-info":[{"award-number":["CRC-2023-00135"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1191793"],"award-info":[{"award-number":["1191793"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Community pharmacists can play a key role in the prevention and management of unintended pregnancy, including in the provision of counselling and by dispensing contraception, and for medication abortion (MA). However, Australian pharmacists\u2019 practice and knowledge of effective contraceptive methods, including long-acting reversible contraception (LARC), is unknown, and few were registered to dispense MA at the time of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Our aim was to understand the knowledge, attitudes and practices of Australian community pharmacists in LARC and MA care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a cross-sectional national online survey of community pharmacists from July until October 2021. Participants were recruited through convenience sampling via mail and partner organisations\u2019 emails, newsletters, and mailing lists. We used descriptive statistical analysis, including counts, proportions, Pearson\u2019s chi-squared tests and Poisson regression for data analysis. Our descriptive survey forms part of the Australian Contraception and Abortion Primary Care Practitioner Support Network (AusCAPPS) mixed-methods project (ACTRN12622000655741).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 533 eligible responses; 72% (n\u2009=\u2009385) self-identified as women, and 71% (n\u2009=\u2009378) were from metropolitan areas. Respondents' correct LARC knowledge varied, with 88% understanding LARC effectiveness, 67.7% understanding return to fertility, and 65.9% understanding LARC suitability for nulliparous women. Most pharmacists were registered to dispense MA (70%; n\u2009=\u2009373), although fewer than half discussed LARC at the time of dispensing MA. Those working outside metropolitan areas were more likely to be registered to dispense MA and feel that they had the knowledge and confidence to dispense MA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>With community pharmacists increasing scope of service in relation to contraception and MA, ongoing education and support will ensure they have accurate information for the provision of LARC and MA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02088-1","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:53:07Z","timestamp":1771933987000},"page":"935-948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-acting reversible contraception and medication abortion: a national descriptive survey of Australian community pharmacist knowledge, attitudes and practices"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-4074","authenticated-orcid":false,"given":"Anisa Rojanapenkul","family":"Assifi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-3447","authenticated-orcid":false,"given":"Sharon","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8256-3330","authenticated-orcid":false,"given":"Satish","family":"Melwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0030-2431","authenticated-orcid":false,"given":"Kirsten I.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6350-843X","authenticated-orcid":false,"given":"Angela","family":"Taft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1035-7110","authenticated-orcid":false,"given":"Deborah","family":"Bateson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-7882","authenticated-orcid":false,"given":"Wendy V.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6158-7376","authenticated-orcid":false,"given":"Danielle","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"2088_CR1","unstructured":"United Nations Department of Economic and Social Affairs. The 2030 agenda for sustainable development: sustainable development goal 3. 2024. https:\/\/sdgs.un.org\/topics\/health-and-population. Accessed 19 Nov 2024."},{"issue":"17","key":"2088_CR2","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1001\/jama.2022.19097","volume":"328","author":"HD Nelson","year":"2022","unstructured":"Nelson HD, Darney BG, Ahrens K, et al. Associations of unintended pregnancy with maternal and infant health outcomes: a systematic review and meta-analysis. JAMA. 2022;328(17):1714\u201329. https:\/\/doi.org\/10.1001\/jama.2022.19097.","journal-title":"JAMA"},{"issue":"21","key":"2088_CR3","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","volume":"366","author":"B Winner","year":"2012","unstructured":"Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366(21):1998\u20132007. https:\/\/doi.org\/10.1056\/NEJMoa1110855.","journal-title":"N Engl J Med"},{"key":"2088_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000429300.39964.d3","author":"JF Peipert","year":"2013","unstructured":"Peipert JF, Madden T, Allsworth JE, et al. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol Surv. 2013. https:\/\/doi.org\/10.1097\/01.ogx.0000429300.39964.d3.","journal-title":"Obstet Gynecol Surv"},{"key":"2088_CR5","unstructured":"International Federation of Gynaecology and Obstetrics. Post-Abortion Contraception including Long-Acting Reversible Contraceptives. 2021. www.figo.org\/resources\/figo-statements\/post-abortion-contraception-including-long-acting-reversible-contraceptive. Accessed 16 Dec 2025."},{"key":"2088_CR6","unstructured":"The Royal College of Obstetricians and Gynaecologists. Best practice in post-abortion contraception. London, UK: Royal College of Obstetricians and Gynaecologists; 2022."},{"key":"2088_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30315-6","author":"J Bearak","year":"2020","unstructured":"Bearak J, Popinchalk A, Ganatra B, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990\u20132019. Lancet Glob Health. 2020. https:\/\/doi.org\/10.1016\/S2214-109X(20)30315-6.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"2088_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.contraception.2008.03.003","volume":"78","author":"S Goodman","year":"2008","unstructured":"Goodman S, Hendlish SK, Reeves MF, et al. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception. 2008;78(2):143\u20138. https:\/\/doi.org\/10.1016\/j.contraception.2008.03.003.","journal-title":"Contraception"},{"issue":"11","key":"2088_CR9","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/humrep\/dew238","volume":"31","author":"H Hognert","year":"2016","unstructured":"Hognert H, Kopp Kallner H, Cameron S, et al. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial. Hum Reprod. 2016;31(11):2484\u201390. https:\/\/doi.org\/10.1093\/humrep\/dew238.","journal-title":"Hum Reprod"},{"issue":"2","key":"2088_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/AOG.0000000000001274","volume":"127","author":"EG Raymond","year":"2016","unstructured":"Raymond EG, Weaver MA, Tan YL, et al. Effect of immediate compared with delayed insertion of etonogestrel implants on medical abortion efficacy and repeat pregnancy: a randomized controlled trial. Obstet Gynecol. 2016;127(2):306\u201312. https:\/\/doi.org\/10.1097\/AOG.0000000000001274.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2088_CR11","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1097\/01.AOG.0000265336.14160.cc","volume":"109","author":"MF Reeves","year":"2007","unstructured":"Reeves MF, Smith KJ, Creinin MD. Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysis. Obstet Gynecol. 2007;109(6):1286\u201394. https:\/\/doi.org\/10.1097\/01.AOG.0000265336.14160.cc.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2088_CR12","doi-asserted-by":"publisher","first-page":"37 e1","DOI":"10.1016\/j.ajog.2011.06.102","volume":"206","author":"SB Rose","year":"2012","unstructured":"Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol. 2012;206(1):37 e1-46. https:\/\/doi.org\/10.1016\/j.ajog.2011.06.102.","journal-title":"Am J Obstet Gynecol"},{"key":"2088_CR13","doi-asserted-by":"publisher","DOI":"10.2471\/B09494","volume-title":"Abortion care guideline","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Abortion care guideline. 2nd ed. Geneva: World Health Organization; 2025. ISBN 978-92-4-010420-4.","edition":"2"},{"key":"2088_CR14","doi-asserted-by":"publisher","first-page":"110979","DOI":"10.1016\/j.contraception.2025.110979","volume":"149","author":"VA Chisari","year":"2025","unstructured":"Chisari VA, Benson H, Benrimoj S, et al. Pharmacist-prescribed contraception using clinical protocols: a review of the gray literature. Contraception. 2025;149:110979. https:\/\/doi.org\/10.1016\/j.contraception.2025.110979.","journal-title":"Contraception"},{"issue":"10262","key":"2088_CR15","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/S0140-6736(20)31785-2","volume":"396","author":"ST Cameron","year":"2020","unstructured":"Cameron ST, Glasier A, McDaid L, et al. Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial. Lancet. 2020;396(10262):1585\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(20)31785-2.","journal-title":"Lancet"},{"issue":"5","key":"2088_CR16","doi-asserted-by":"publisher","first-page":"e205252","DOI":"10.1001\/jamanetworkopen.2020.5252","volume":"3","author":"MI Rodriguez","year":"2020","unstructured":"Rodriguez MI, Edelman AB, Skye M, et al. Association of pharmacist prescription with dispensed duration of hormonal contraception. JAMA Netw Open. 2020;3(5):e205252. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.5252.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2088_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.contraception.2020.05.016","volume":"102","author":"MI Rodriguez","year":"2020","unstructured":"Rodriguez MI, Edelman AB, Skye M, et al. Reasons for and experience in obtaining pharmacist prescribed contraception. Contraception. 2020;102(4):259\u201361. https:\/\/doi.org\/10.1016\/j.contraception.2020.05.016.","journal-title":"Contraception"},{"key":"2088_CR18","unstructured":"Zusman EZ, Bouma S, Davies C et al. Beyond pills: exploring pharmacists\u2019 role in long-acting reversible contraception services. In: Proceedings of the BC provincial consensus meeting. Vancouver, BC: University of British Columbia; 2025."},{"key":"2088_CR19","unstructured":"Government of British Columbia. Pharmacy Services in B.C. Victoria, BC, Canada. 2025. https:\/\/www2.gov.bc.ca\/gov\/content\/health\/accessing-health-care\/pharmacy-services#contraception. Accessed 22 Dec 2025."},{"issue":"6","key":"2088_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.japh.2018.06.020","volume":"58","author":"MI Rodriguez","year":"2018","unstructured":"Rodriguez MI, Biel FM, Swartz JJ, et al. Pharmacists\u2019 experience with prescribing hormonal contraception in Oregon. J Am Pharm Assoc. 2018;58(6):608\u201313. https:\/\/doi.org\/10.1016\/j.japh.2018.06.020.","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"2088_CR21","doi-asserted-by":"publisher","first-page":"647.e1","DOI":"10.1016\/j.ajog.2021.06.089","volume":"225","author":"MI Rodriguez","year":"2021","unstructured":"Rodriguez MI, Skye M, Edelman AB, et al. Association of pharmacist prescription and 12-month contraceptive continuation rates. Am J Obstet Gynecol. 2021;225(6):647.e1-647.e9. https:\/\/doi.org\/10.1016\/j.ajog.2021.06.089.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2088_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5694\/mja17.01094","volume":"209","author":"AJ Taft","year":"2018","unstructured":"Taft AJ, Shankar M, Black KI, et al. Unintended and unwanted pregnancy in Australia: a cross-sectional, national random telephone survey of prevalence and outcomes. Med J Aust. 2018;209(9):407\u20138. https:\/\/doi.org\/10.5694\/mja17.01094.","journal-title":"Med J Aust"},{"key":"2088_CR23","unstructured":"Department of Health. National Women's Health Strategy 2020\u20132030. Canberra: Department of Health, Australian Government; 2019."},{"issue":"1","key":"2088_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/ajo.13257","volume":"61","author":"LE Grzeskowiak","year":"2021","unstructured":"Grzeskowiak LE, Calabretto H, Amos N, et al. Changes in use of hormonal long-acting reversible contraceptive methods in Australia between 2006 and 2018: a population-based study. Aust N Z J Obstet Gynaecol. 2021;61(1):128\u201334. https:\/\/doi.org\/10.1111\/ajo.13257.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"9","key":"2088_CR25","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/phar.1457","volume":"34","author":"S Rafie","year":"2014","unstructured":"Rafie S, McIntosh J, Shealy KM, et al. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women\u2019s health practice and research network of the American College of Clinical Pharmacy. Pharmacotherapy. 2014;34(9):991\u20139. https:\/\/doi.org\/10.1002\/phar.1457.","journal-title":"Pharmacotherapy"},{"issue":"8","key":"2088_CR26","doi-asserted-by":"publisher","first-page":"e073154","DOI":"10.1136\/bmjopen-2023-073154","volume":"13","author":"D Mazza","year":"2023","unstructured":"Mazza D, Assifi AR, Hussainy SY, et al. Expanding community pharmacists\u2019 scope of practice in relation to contraceptive counselling and referral: a protocol for a pragmatic, stepped-wedge, cluster randomised trial (ALLIANCE). BMJ Open. 2023;13(8):e073154. https:\/\/doi.org\/10.1136\/bmjopen-2023-073154.","journal-title":"BMJ Open"},{"key":"2088_CR27","unstructured":"Australian Government Department of Health and Aged Care. Australian product information: MS2-Step (mifepristone and misoprostol) tablets. Therapeutic Goods Administration. 2024. https:\/\/www.tga.gov.au\/sites\/default\/files\/2024-02\/auspar-ms-2step-composite-pack-240214-pi.pdf. Accessed 03 June 2025."},{"key":"2088_CR28","unstructured":"MSI Australia. Becoming a prescriber or dispenser. 2023. https:\/\/www.msiaustralia.org.au\/for-clinicians\/become-a-prescriber-or-dispenser\/. Accessed 14 June 2023."},{"key":"2088_CR29","volume-title":"Dispenser and prescriber program\u2014December update 2021","author":"MS Health","year":"2021","unstructured":"MS Health. Dispenser and prescriber program\u2014December update 2021. Melbourne: MSI Reproductive Choices; 2021."},{"key":"2088_CR30","unstructured":"Department of Health. National Health Workforce Dataset. In: Health workforce data\u2014pharmacist. Commonwealth of Australia, Canberra. 2022. https:\/\/hwd.health.gov.au\/datatool\/. Accessed 1 July 2024."},{"key":"2088_CR31","unstructured":"NAB Health. Part 1: The health consumer\u2014NAB behavioural and industrial economics: National Bank Australia Limited; 2022. November 2022."},{"key":"2088_CR32","unstructured":"The Pharmacy Guild of Australia. Vital facts on community pharmacy. Canberra: The Pharmacy Guild of Australia; 2024."},{"key":"2088_CR33","doi-asserted-by":"publisher","DOI":"10.4081\/gh.2015.358","author":"MR McGrail","year":"2015","unstructured":"McGrail MR, Humphreys JS. Spatial access disparities to primary health care in rural and remote Australia. Geospat Health. 2015. https:\/\/doi.org\/10.4081\/gh.2015.358.","journal-title":"Geospat Health"},{"issue":"2","key":"2088_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/bmjsrh-2022-201623","volume":"49","author":"PLM Buckingham","year":"2023","unstructured":"Buckingham PLM, Hussainy S, Soon J, et al. Improving access to quality contraceptive counselling in community pharmacy: examining the knowledge, attitudes and practices of community pharmacists in Australia. BMJ Sex Reprod Health. 2023;49(2):87. https:\/\/doi.org\/10.1136\/bmjsrh-2022-201623.","journal-title":"BMJ Sex Reprod Health"},{"issue":"12","key":"2088_CR35","doi-asserted-by":"publisher","first-page":"e065583","DOI":"10.1136\/bmjopen-2022-065583","volume":"12","author":"D Mazza","year":"2022","unstructured":"Mazza D, James S, Black K, et al. Increasing the availability of long-acting reversible contraception and medical abortion in primary care: The Australian contraception and abortion primary care practitioner support network (AusCAPPS) cohort study protocol. BMJ Open. 2022;12(12):e065583. https:\/\/doi.org\/10.1136\/bmjopen-2022-065583.","journal-title":"BMJ Open"},{"issue":"3","key":"2088_CR36","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G. Improving the quality of web surveys: The checklist for reporting results of internet e-surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. https:\/\/doi.org\/10.2196\/jmir.6.3.e34.","journal-title":"J Med Internet Res"},{"issue":"10","key":"2088_CR37","doi-asserted-by":"publisher","first-page":"e012491","DOI":"10.1136\/bmjopen-2016-012491","volume":"6","author":"D Mazza","year":"2016","unstructured":"Mazza D, Black K, Taft A, et al. Increasing the uptake of long-acting reversible contraception in general practice: The Australian contraceptive choice project (ACCORd) cluster randomised controlled trial protocol. BMJ Open. 2016;6(10):e012491. https:\/\/doi.org\/10.1136\/bmjopen-2016-012491.","journal-title":"BMJ Open"},{"key":"2088_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186487","author":"HE Jones","year":"2017","unstructured":"Jones HE, O\u2019Connell White K, Norman WV, et al. First trimester medication abortion practice in the United States and Canada. PLoS ONE. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0186487.","journal-title":"PLoS ONE"},{"issue":"4","key":"2088_CR39","first-page":"e209","volume":"62","author":"WV Norman","year":"2016","unstructured":"Norman WV, Guilbert ER, Okpaleke C, et al. Abortion health services in Canada: results of a 2012 national survey. Can Fam Phys. 2016;62(4):e209\u201317.","journal-title":"Can Fam Phys"},{"issue":"2","key":"2088_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"2088_CR41","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"key":"2088_CR42","unstructured":"StataCorp. Stata statistical software: Release 18. College Station, 2023."},{"key":"2088_CR43","unstructured":"Department of Health. Modified Monash Model. Commonwealth of Australia. 2020. https:\/\/www.health.gov.au\/health-workforce\/health-workforce-classifications\/modified-monash-model. Accessed 14 Apr 2020."},{"key":"2088_CR44","unstructured":"Australian Bureau of Statistics. 2021 Census highlights increasing cultural diversity. ABS. 2022. https:\/\/www.abs.gov.au\/media-centre\/media-releases\/2021-census-highlights-increasing-cultural-diversity. Accessed 04 June 2025."},{"issue":"5","key":"2088_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.amepre.2018.06.006","volume":"55","author":"E Fox","year":"2018","unstructured":"Fox E, Reyna A, Malcolm NM, et al. Client preferences for contraceptive counseling: a systematic review. Am J Prev Med. 2018;55(5):691\u2013702. https:\/\/doi.org\/10.1016\/j.amepre.2018.06.006.","journal-title":"Am J Prev Med"},{"issue":"9","key":"2088_CR46","doi-asserted-by":"publisher","first-page":"476","DOI":"10.5694\/mja2.51472","volume":"216","author":"LE Grzeskowiak","year":"2022","unstructured":"Grzeskowiak LE, Rumbold AR, Subasinghe A, et al. Long-acting reversible contraception use after medical abortion is associated with reduced likelihood of a second medical abortion. Med J Aust. 2022;216(9):476\u20137. https:\/\/doi.org\/10.5694\/mja2.51472.","journal-title":"Med J Aust"},{"issue":"3","key":"2088_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1071\/py22212","volume":"29","author":"T Dev","year":"2023","unstructured":"Dev T, Buckingham P, Mazza D. Women\u2019s perspectives of direct pharmacy access to oral contraception. Aust J Prim Health. 2023;29(3):235\u201343. https:\/\/doi.org\/10.1071\/py22212.","journal-title":"Aust J Prim Health"},{"key":"2088_CR48","unstructured":"Australian Government Department of Health and Aged Care. Amendments to restrictions for prescribing of MS-2 Step (mifepristone and misoprostol). Canberra: Commonwealth of Australia; 2023."},{"issue":"1","key":"2088_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cptl.2019.10.005","volume":"12","author":"RH Stone","year":"2020","unstructured":"Stone RH, Rafie S, Griffin B, et al. Pharmacist self-perception of readiness to prescribe hormonal contraception and additional training needs. Curr Pharm Teach Learn. 2020;12(1):27\u201334. https:\/\/doi.org\/10.1016\/j.cptl.2019.10.005.","journal-title":"Curr Pharm Teach Learn"},{"issue":"6","key":"2088_CR50","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/17151635211034534","volume":"154","author":"JA Soon","year":"2021","unstructured":"Soon JA, Whelan AM, Yuksel N, et al. Enhancing access to contraception through pharmacist prescribing across Canada. Can Pharm J. 2021;154(6):356\u201362. https:\/\/doi.org\/10.1177\/17151635211034534.","journal-title":"Can Pharm J"},{"key":"2088_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riae062","author":"RA Nona","year":"2024","unstructured":"Nona RA, Ray RA, Taylor SM, et al. Knowledge, attitudes, and practices of community pharmacists providing over-the-counter emergency hormonal contraception: a scoping review. Int J Pharm Pract. 2024. https:\/\/doi.org\/10.1093\/ijpp\/riae062.","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"2088_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jac5.1539","volume":"5","author":"JL Newlon","year":"2022","unstructured":"Newlon JL, Reed JB, Stone RH, et al. Pharmacist-prescribed hormonal contraception services: a systematic review of implementation studies. J Am Coll Clin Pharm. 2022;5(1):85\u201398. https:\/\/doi.org\/10.1002\/jac5.1539.","journal-title":"J Am Coll Clin Pharm"},{"issue":"2","key":"2088_CR53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.contraception.2020.10.012","volume":"103","author":"LM Eckhaus","year":"2021","unstructured":"Eckhaus LM, Ti AJ, Curtis KM, et al. Patient and pharmacist perspectives on pharmacist-prescribed contraception: a systematic review. Contraception. 2021;103(2):66\u201374. https:\/\/doi.org\/10.1016\/j.contraception.2020.10.012.","journal-title":"Contraception"},{"issue":"4","key":"2088_CR54","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.japh.2022.02.012","volume":"62","author":"B Failla","year":"2022","unstructured":"Failla B, Vest K, Lynch S, et al. Impact of a hormonal contraceptive training program for pharmacists. J Am Pharm Assoc. 2022;62(4):1287-1295.e4. https:\/\/doi.org\/10.1016\/j.japh.2022.02.012.","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"2088_CR55","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.contraception.2016.08.011","volume":"95","author":"PA Lohr","year":"2017","unstructured":"Lohr PA, Lyus R, Prager S. Use of intrauterine devices in nulliparous women. Contraception. 2017;95(6):529\u201337. https:\/\/doi.org\/10.1016\/j.contraception.2016.08.011.","journal-title":"Contraception"},{"issue":"4","key":"2088_CR56","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/AOG.0b013e31824aca39","volume":"119","author":"CP Tyler","year":"2012","unstructured":"Tyler CP, Whiteman MK, Zapata LB, et al. Health care provider attitudes and practices related to intrauterine devices for nulliparous women. Obstet Gynecol. 2012;119(4):762\u201371. https:\/\/doi.org\/10.1097\/AOG.0b013e31824aca39.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2088_CR57","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.contraception.2014.02.008","volume":"89","author":"AT Luchowski","year":"2014","unstructured":"Luchowski AT, Anderson BL, Power ML, et al. Obstetrician\u2013gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations. Contraception. 2014;89(6):572\u20137. https:\/\/doi.org\/10.1016\/j.contraception.2014.02.008.","journal-title":"Contraception"},{"issue":"5","key":"2088_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.contraception.2010.01.010","volume":"81","author":"RJ Lyus","year":"2010","unstructured":"Lyus RJ, Lohr PA, Prager SW, et al. Use of the Mirena\u2122 LNG-IUS and Paragard\u2122 CuT380A intrauterine devices in nulliparous women. Contraception. 2010;81(5):367\u201371. https:\/\/doi.org\/10.1016\/j.contraception.2010.01.010.","journal-title":"Contraception"},{"key":"2088_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy7040154","author":"R Micallef","year":"2019","unstructured":"Micallef R, Kayyali R. A systematic review of models used and preferences for continuing education and continuing professional development of pharmacists. Pharmacy. 2019. https:\/\/doi.org\/10.3390\/pharmacy7040154.","journal-title":"Pharmacy"},{"issue":"3","key":"2088_CR60","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jpag.2015.09.001","volume":"29","author":"SE Rubin","year":"2016","unstructured":"Rubin SE, Felsher M, Korich F, et al. Urban adolescents\u2019 and young adults\u2019 decision-making process around selection of intrauterine contraception. J Pediatr Adolesc Gynecol. 2016;29(3):234\u20139. https:\/\/doi.org\/10.1016\/j.jpag.2015.09.001.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"2088_CR61","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/jmwh.13280","volume":"66","author":"H Mahony","year":"2021","unstructured":"Mahony H, Spinner C, Vamos CA, et al. Social network influences on young women\u2019s choice to use long-acting reversible contraception: A systematic review. J Midwifery Womens Health. 2021;66(6):758\u201371. https:\/\/doi.org\/10.1111\/jmwh.13280.","journal-title":"J Midwifery Womens Health"},{"issue":"4","key":"2088_CR62","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/10410236.2021.1980249","volume":"38","author":"A Cooke-Jackson","year":"2023","unstructured":"Cooke-Jackson A, Rubinsky V, Gunning JN. Wish i would have known that before i started using it\u201d: contraceptive messages and information seeking among young women. Health Commun. 2023;38(4):834\u201343. https:\/\/doi.org\/10.1080\/10410236.2021.1980249.","journal-title":"Health Commun"},{"issue":"4","key":"2088_CR63","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/eb-2016-102516","volume":"20","author":"ED Berlan","year":"2017","unstructured":"Berlan ED. Healthcare providers need to address misconceptions young women have around IUDs and their fertility. Evid Based Nurs. 2017;20(4):124. https:\/\/doi.org\/10.1136\/eb-2016-102516.","journal-title":"Evid Based Nurs"},{"issue":"8","key":"2088_CR64","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5694\/mja2.51275","volume":"215","author":"AK Subasinghe","year":"2021","unstructured":"Subasinghe AK, McGeechan K, Moulton JE, et al. Early medical abortion services provided in Australian primary care. Med J Aust. 2021;215(8):366\u201370. https:\/\/doi.org\/10.5694\/mja2.51275.","journal-title":"Med J Aust"},{"issue":"5","key":"2088_CR65","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.2196\/jmir.9717","volume":"20","author":"AF Cartwright","year":"2018","unstructured":"Cartwright AF, Karunaratne M, Barr-Walker J, et al. Identifying national availability of abortion care and distance from major US cities: systematic online search. J Med Internet Res. 2018;20(5):e186. https:\/\/doi.org\/10.2196\/jmir.9717.","journal-title":"J Med Internet Res"},{"issue":"3","key":"2088_CR66","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1071\/PY22194","volume":"29","author":"S Srinivasan","year":"2023","unstructured":"Srinivasan S, Botfield JR, Mazza D. Utilising healthpathways to understand the availability of public abortion in Australia. Aust J Prim Health. 2023;29(3):260\u20137. https:\/\/doi.org\/10.1071\/PY22194.","journal-title":"Aust J Prim Health"},{"issue":"1","key":"2088_CR67","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s12913-016-1846-z","volume":"16","author":"A Dawson","year":"2016","unstructured":"Dawson A, Bateson D, Estoesta J, et al. Towards comprehensive early abortion service delivery in high-income countries: insights for improving universal access to abortion in Australia. BMC Health Serv Res. 2016;16(1):612. https:\/\/doi.org\/10.1186\/s12913-016-1846-z.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"2088_CR68","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ajo.12298","volume":"55","author":"C de Costa","year":"2015","unstructured":"de Costa C, Douglas H, Hamblin J, et al. Abortion law across Australia: a review of nine jurisdictions. Aust N Z J Obstet Gynaecol. 2015;55(2):105\u201311. https:\/\/doi.org\/10.1111\/ajo.12298.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"2088_CR69","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1007\/s11135-021-01252-1","volume":"56","author":"M Griffin","year":"2022","unstructured":"Griffin M, Martino RJ, LoSchiavo C, et al. Ensuring survey research data integrity in the era of internet bots. Qual Quant. 2022;56(4):2841\u201352. https:\/\/doi.org\/10.1007\/s11135-021-01252-1.","journal-title":"Qual Quant"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02088-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02088-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02088-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:16:36Z","timestamp":1778746596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02088-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":69,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02088-1","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DB has provided education for clinicians at sessions sponsored by Bayer, Mayne Pharma and Besins Healthcare. DM has received research funding and advisory board honoraria from Bayer and Organon. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Ethical approval was granted by the Monash University Human Research Ethics Committee (#28002).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent was implied by survey completion.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}